• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

肺毛霉病——病例系列

Pulmonary mucormycosis-a case series.

作者信息

Benjamin Santhosh Regini, Narayanan Deepak, Chandy Sujith Thomas, Gnanamuthu Birla Roy, Michael Joy Sarojini, Kodiatte Thomas Alex

机构信息

The Department of Cardiothoracic Surgery, The Christian Medical College, Vellore, Tamil Nadu 632004 India.

The Department of Pulmonary Medicine, The Christian Medical College, Vellore, Tamil Nadu 632004 India.

出版信息

Indian J Thorac Cardiovasc Surg. 2022 Mar;38(2):177-182. doi: 10.1007/s12055-021-01272-4. Epub 2021 Oct 30.

DOI:10.1007/s12055-021-01272-4
PMID:34744334
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8556863/
Abstract

Pulmonary mucormycosis (PM) is a rare disease. Literature about the surgical management of PM in India is sparse. Recently, there has been a surge in the number of cases of mucormycosis in association with the coronavirus disease 2019 (COVID-19) pandemic, igniting the interest in PM. Hence, we endeavoured to analyse our surgical experience in treating PM prior to the pandemic, in a tertiary care centre, to provide insight into this disease. Data of 10 adult patients with isolated PM, who underwent surgery between the years 2009 and 2020, and maintained in our departmental database, were retrieved and analysed.

摘要

肺毛霉菌病（PM）是一种罕见疾病。关于印度PM外科治疗的文献稀少。最近，与2019冠状病毒病（COVID-19）大流行相关的毛霉菌病病例数激增，引发了对PM的关注。因此，我们努力分析我们在一家三级医疗中心在大流行之前治疗PM的外科经验，以深入了解这种疾病。检索并分析了2009年至2020年间在我们科室接受手术并保存在科室数据库中的10例孤立性PM成年患者的数据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d7a/8857360/b1d4b29d5c60/12055_2021_1272_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d7a/8857360/32b75f9e169c/12055_2021_1272_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d7a/8857360/62ffcb2c4f40/12055_2021_1272_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d7a/8857360/b1d4b29d5c60/12055_2021_1272_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d7a/8857360/32b75f9e169c/12055_2021_1272_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d7a/8857360/62ffcb2c4f40/12055_2021_1272_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d7a/8857360/b1d4b29d5c60/12055_2021_1272_Fig3_HTML.jpg

相似文献

1
Pulmonary mucormycosis-a case series.肺毛霉病——病例系列
Indian J Thorac Cardiovasc Surg. 2022 Mar;38(2):177-182. doi: 10.1007/s12055-021-01272-4. Epub 2021 Oct 30.
2
Clinicopathological Study of Mucormycosis in COVID-19 Patients: Experience From a Tertiary Care Center in South India.COVID-19患者毛霉菌病的临床病理研究：来自印度南部一家三级医疗中心的经验
Cureus. 2022 Mar 10;14(3):e23016. doi: 10.7759/cureus.23016. eCollection 2022 Mar.
3
Management outcomes of mucormycosis in COVID-19 patients: A preliminary report from a tertiary care hospital.新型冠状病毒肺炎患者毛霉菌病的治疗结果：来自一家三级医院的初步报告
Med J Armed Forces India. 2021 Jul;77(Suppl 2):S289-S295. doi: 10.1016/j.mjafi.2021.06.009. Epub 2021 Jul 26.
4
Pulmonary Artery Pseudoaneurysm in COVID-19-Associated Pulmonary Mucormycosis: Case Series and Systematic Review of the Literature.COVID-19 相关肺毛霉菌病中的肺动脉假性动脉瘤：病例系列和文献系统评价。
Mycopathologia. 2022 Feb;187(1):31-37. doi: 10.1007/s11046-021-00610-9. Epub 2021 Dec 22.
5
Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India.COVID-19 相关毛霉菌病：全球及印度病例报告的系统综述。
Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102146. doi: 10.1016/j.dsx.2021.05.019. Epub 2021 May 21.
6
COVID-19 and mucormycosis superinfection: the perfect storm.COVID-19 与毛霉菌感染：完美风暴。
Infection. 2021 Oct;49(5):833-853. doi: 10.1007/s15010-021-01670-1. Epub 2021 Jul 24.
7
Two Uncommon Presentations of COVID-19-Associated Mucormycosis.新型冠状病毒肺炎相关毛霉菌病的两种罕见表现
Cureus. 2022 Jan 14;14(1):e21229. doi: 10.7759/cureus.21229. eCollection 2022 Jan.
8
Mucormycosis and COVID-19 an epidemic in a pandemic?毛霉菌病与新冠疫情——大流行中的一种流行病？
Nepal J Epidemiol. 2021 Jun 30;11(2):1034-1039. doi: 10.3126/nje.v11i2.37342. eCollection 2021 Jun.
9
Cut it out! Thoracic surgeon's approach to pulmonary mucormycosis and the role of surgical resection in survival.切除它！胸外科医生治疗肺毛霉菌病的方法以及手术切除对生存的作用。
Mycoses. 2019 Oct;62(10):893-907. doi: 10.1111/myc.12954. Epub 2019 Aug 6.
10
Coronavirus Disease-Associated Mucormycosis from a Tertiary Care Hospital in India: A Case Series.印度一家三级护理医院的冠状病毒病相关毛霉菌病：病例系列
Cureus. 2021 Jul 3;13(7):e16152. doi: 10.7759/cureus.16152. eCollection 2021 Jul.

引用本文的文献

1
An overview on the principles of management of haemoptysis.咯血管理原则概述。
Indian J Thorac Cardiovasc Surg. 2023 Sep;39(5):505-515. doi: 10.1007/s12055-023-01547-y. Epub 2023 Aug 21.
2
COVID-19-Associated Pulmonary Mucormycosis.新型冠状病毒肺炎相关肺毛霉病
J Fungi (Basel). 2022 Jul 5;8(7):711. doi: 10.3390/jof8070711.
3
Definition, diagnosis, and management of COVID-19-associated pulmonary mucormycosis: Delphi consensus statement from the Fungal Infection Study Forum and Academy of Pulmonary Sciences, India.
COVID-19 相关肺毛霉菌病的定义、诊断和管理：印度真菌感染研究论坛和肺病科学院的德尔菲共识声明。
Lancet Infect Dis. 2022 Sep;22(9):e240-e253. doi: 10.1016/S1473-3099(22)00124-4. Epub 2022 Apr 4.